If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
TOBI PODHALER tobramycin 28 mg hard capsule for inhalation blister pack with Podhaler device AUST R: 182302Active ingredients:
tobramycin
Dosage form:
Capsule, hard
Sponsor:
Viatris Pty Ltd
Phone:
1800 314 527
|
From
14 Nov 2025
to
27 Feb 2026
|
Shortage status:
Current
Availability:
Emergency Supply Only
Reason:
Manufacturing
Management action:
The sponsor is working to expedite the next shipment.
|
Pfizer (Australia) TOBRAMYCIN (as sulfate) PF 80 mg/2 mL injection ampoule AUST R: 10776Active ingredients:
tobramycin
Dosage form:
Injection, solution
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
From
08 Dec 2025
to
27 Feb 2026
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Manufacturing
Management action:
Sponsor is closely controlling the supply. Alternative brands are available. An overseas registered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
|
TOBRAMYCIN WKT tobramycin 300mg/5mL solution for inhalation ampoules AUST R: 279353Active ingredients:
tobramycin
Dosage form:
Inhalation, conventional
Sponsor:
Arrotex Pharmaceuticals Pty Ltd
Phone:
1800 195 055
|
From
08 May 2026
to
22 May 2026
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Manufacturing
Management action:
The sponsor is working to expedite the next shipment.
|
DBL TOBRAMYCIN tobramycin 80mg/2mL injection BP vial AUST R: 75686Active ingredients:
tobramycin
Dosage form:
Injection, solution
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
Deletion from market:
01 Apr 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative generic product is available.
|
TOBI tobramycin 300mg/5mL solution for inhalation ampoule AUST R: 73172Active ingredients:
tobramycin
Dosage form:
Inhalation, conventional
Sponsor:
Viatris Pty Ltd
Phone:
1800 314 527
|
Deletion from market:
30 Jan 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative brand is available.
|
TOBRAMYCIN SUN tobramycin 300 mg/5 mL solution for inhalation ampoule AUST R: 285709Active ingredients:
tobramycin
Dosage form:
Inhalation, conventional
Sponsor:
Sun Pharma ANZ Pty Ltd
Phone:
0298872600
|
Deletion from market:
01 May 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Manufacturing
Management action:
Alternative generic products are available.
|